Cipla (CIPLA) — Financial Results

Cipla reported Q3 FY26 consolidated revenue of ₹7,074 crores, largely flat YoY despite a known decline in gRevlimid sales. India business returned to strong double-digit growth of 10% YoY, with Chronic mix improving to 62.3%. North America revenue stood at $167 million. However, EBITDA fell 36.9% to ₹1,255 crores and PAT declined 57% to ₹676 crores. R&D investments increased 37.4% YoY to ₹494 crores. Net cash position strengthened to ₹10,229 crores.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does this financial results affect Cipla Limited's outlook?" "What did Cipla Limited announce on 23 January 2026?" "Is this positive or negative for CIPLA?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 23 January 2026

VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Financial Results SBILIFE SBI Life Insurance Company Limited Corporate Action SHRIRAMFIN Shriram Finance Limited Financial Results SHRIRAMFIN Shriram Finance Limited Financial Results WIPRO Wipro Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.